Video

DateTitle
21/12/202018 Minutes with Zelira Therapeutics – 180 Markets
16/11/2020The West Australian – Perth family describes their desperation when they sought cannabis for autistic, suicidal son
05/11/2020OPINION | Reform should be driving protection for medicinal cannabis patients
19/10/2020Cantor Fitzgerald Hosts Fireside Chat with Zelira Therapeutics
29/09/2020Investor buzz around cannabis stocks with new treatments
16/09/2020Zelira Therapeutics (ASX:ZLD) launches Zenivol in Australia
16/09/2020Zelira Therapeutics’ insomnia treatment gets TGA tick
16/09/2020Zelira Therapeutics launches Zenivol™ product in Australia after TGA adds to Special Access Scheme
15/09/2020Medicinal cannabis trial could help retired AFL players manage chronic pain
08/09/2020Zelira Therapeutics forms subsidiary to launch hemp-derived oral care products in the USA
24/08/2020Proactive – Zelira Therapeutics expands US network with Louisiana launch of HOPE products for autism sufferers
20/08/2020Zelira Therapeutics expands US network with Louisiana launch of HOPE products for autism sufferers
19/08/2020Sequoia Initiation Research Report, 19 August 2020
17/08/2020Zelira Therapeutics MD shows faith in medical cannabis strategy with placement participation
07/08/2020Proactive – Three medical cannabis companies in focus at Proactive’s webinar on August 11
16/07/2020Starts at 60 – Suffer from chronic pain? Medicinal cannabis could be the answer
14/07/2020TechInvest – Zelira obtains key data in cannabis dose escalation study
14/07/2020The Market Herald – Zelira Therapeutics (ASX:ZLD) confirms ZTL-103 is safe and well-tolerated
14/07/2020Proactive – Zelira Therapeutics dose escalation trial for chronic pain meets safety and efficacy endpoints
14/07/2020Stockhead – Pot stock Zelira Therapeutics successfully passes another Phase I clinical trial